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1. Introduction 
The World Health Organization (WHO) estimates that more than two million deaths occur 
each year as a consequence of air pollution exposure (Mackay et al., 2004). This estimate, 
which some scientists consider conservative, is based on hundreds of scientific studies 
showing an association between exposure to air pollution and heart as well as lung related 
illness and death. However, scientists do not understand the sequence of events in the 
human body that link air pollution exposure to illness and death. Understanding these 
events and their order is a major focus of ongoing medical research.  
The aims of this chapter are to first introduce the reader to air pollution and then to briefly 
present the current scientific understanding of the biological events that link particulate 
matter air pollution exposure to illness and death. The chapter concludes with suggestions 
for future actions to reduce the health consequence of air pollution exposure. This chapter 
does not consider the effects of indoor air pollutants such as tobacco smoke, or smoke from 
cooking fires because these topics are considered elsewhere in this book. 
Air pollution is a complicated mixture of airborne particulates combined with gases, mist 
and fog. Its composition is highly variable with differences observed between rural locations 
and cities, between individual cities, and even between regions within cities. The gases in air 
pollution such as ozone, carbon monoxide, sulphur dioxide and nitrogen dioxide are 
considered pollutants at high levels because they have a moderate association with human 
illness (morbidity) and death (mortality) (Lipfert et al., 1995; Morris et al., 1995; Sheppard et 
al., 1999; Wichmann et al., 1989). When small enough to enter the deep regions of the body, 
particles in air pollution have been shown to have a strong association with human 
morbidity and mortality, particularly with heart (cardiovascular) and lung (pulmonary) 
morbidity and mortality (Dockery et al., 1993; Hong et al., 1999; Lin et al., 2005; Pope, 1989; 
Samet et al., 2000; Stieb et al., 2002; Wichmann et al., 1989). These small particles are called 
particulate matter.  
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1.1 Particulate matter  
 
The WHO defines particulate matter (PM) as a stable atmospheric suspension of solid and 
liquid particles with variable composition, origin and an aerodynamic diameter ranging 
from ~0.000000002 to ~0.0001 meter (m). Particles with an aerodynamic diameter smaller 
than 0.00001 m, or 10 micrometer (µm), are strongly associated with human morbidity and 
mortality and are commonly referred to as PM10.  
1.1.1 Particle size 
Particle size plays a central role in determining the biological consequences of PM exposure 
(Finlayson-Pitts et al., 2000; Oberdorster, 2001). Particle size has been shown to determine: 1. 
the location of particle deposition in the airway and lungs, 2. the amount of surface area that 
can contact tissues, and 3. the rate of particle clearance from the lungs (Kendall et al., 2002; 
Oberdorster et al., 1994; Sioutas et al., 2005; West et al., 2003).  
Particles larger than 10 µm in diameter have such high inertia that they cannot turn the tight 
corners of the airway. As a result these particles run into the mucous covered walls of the 
nose and upper airway where they become trapped. The mucous holds these particles until 
the particles are cleared through mucociliary clearance. Due to the location of deposition in 
the upper airway, particles larger than 10 µm in diameter are not associated with human 
illness. Mucociliary clearance is a cleaning system in the airway made of small hairs called 
cilia. Cilia transport mucous and any debris the mucous has trapped to the upper airway for 
clearance through the nose or swallowing into the stomach.  
Particles smaller than 10 µm in diameter have a small enough inertia that the particles can 
navigate the upper airway and be inhaled deep into the lungs. Particle deposition on the 
alveolar surface, which is where gas exchange occurs in the lungs, is linked to pulmonary 
and cardiovascular morbidity and mortality (Dockery et al., 1993; Seaton et al., 1995). 
Analysis of PM10 has recently revealed three fractions of PM10 with distinct regions of 
deposition in the lungs. These three fractions are the coarse fraction, the fine fraction and the 
ultrafine fraction. Each fraction has different formation processes, composition, atmospheric 
lifetimes and biological consequences (Sioutas et al., 2005). 
The coarse fraction is composed of particles between 10 and 2.5 µm in aerodynamic diameter 
that are produced by mechanical processes such as wind erosion. These larger particulates 
are affected by gravitational settling and typically settle out of the lower atmosphere within 
hours of formation (Hinds, 1999; Sioutas et al., 2005). The coarse fraction is thought to 
deposit in the upper airway, and to penetrate only as deep as the pharynx and occasionally 
into the trachea. Similar to the greater-than-10 µm fraction, particles deposited in these areas 
are cleared from the body through the nose or by coughing and swallowing. The particles 
that enter deep into the pulmonary system are carried up the trachea by the mucociliary 
escalator and swallowed into the stomach.  
PM10 – Atmospheric particles with 
an aerodynamic diameter smaller 
than 0.00001 meter or 10 micrometer 
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The fine fraction is composed of particles between 2.5 and 0.1 µm in size and is called PM2.5. 
These particles account for the greatest mass of airborne particulates and are generally 
formed through human activities. Fine particle formation typically occurs when gas 
molecules condense together to form particles through heterogeneous and homogeneous 
nucleation, as well as condensation onto already existing atmospheric particles (Finlayson-
Pitts et al., 2000; Hinds, 1999; Sioutas et al., 2005). The small size of this fraction of particles 
makes them less susceptible to gravitational settling resulting in atmospheric lifetimes in the 
order of days, and the ability to be transported long distances by wind currents. The fine 
particles are inhaled into the conducting airways of the lungs. The mucociliary escalator also 
clears particles deposited in these areas. Some particles travel beyond the conducting 
airways into the alveoli where they become trapped in the fluid layer of the alveolar wall. In 
the alveoli, a population of resident white blood cells, called alveolar macrophages, patrols 
the alveolar surfaces immediately below the layer of fluid. Particles deposited on the 
alveolar wall are taken up by these alveolar macrophages. The macrophages are then 
transported out of the lungs by the mucociliary escalator (Dockery et al., 1994) or taken to 
the pulmonary lymph nodes (Harmsen et al., 1985). A small population of free particles that 
are not taken up by alveolar macrophages may move into the lung tissue, and then be taken 
into the lymphatic vessels for processing in the pulmonary lymph nodes (Dockery et al., 
1994). Depending on their solubility, particles may remain in the pulmonary lymph nodes 
from several days to thousands of days (Brain et al., 1994). 
 
The ultrafine fraction is composed of particles that are smaller than 0.1 µm in aerodynamic 
diameter (PM0.1). These particles have traditionally been considered the fresh emissions in 
pollution that have yet to undergo condensation or modification processes. The composition 
of fine particles is varied, characteristically composed of ammonium, carbon, nitrate and 
sulphate as well as trace metals formed in the combustion processes (Sioutas et al., 2005). 
This fraction of the smallest particles accounts for the greatest number of atmospheric 
particles with the largest surface area-to-mass ratio. These particles are primarily deposited 
on the alveolar surface (Naga et al., 2005; Wang et al., 2002; West et al., 2003). Smaller 
particles are thought to move into the pulmonary circulation as evidenced by their 
accumulation in the lymph nodes, spleen, heart, liver and even the bladder and brain (Brain 
et al., 1994; Harmsen et al., 1985; Nemmar et al., 2002; Oberdorster et al., 2000; Oberdorster 
et al., 2004; Peters et al., 2006; Semmler et al., 2004). 
The large surface-area-to-volume/mass ratios of fine and ultrafine particles may account for 
their negative effect on human health. Evidence suggests that the larger the surface area the 
greater the impact of the particle. Smaller particles are known to have the greatest surface 
Coarse - PM10: Deposited in the upper airway; until recently 
associated with human illness. 
Fine - PM2.5: Deposited deep into the lungs, some deposition 
on the alveolar surface; associated with human illness. 
Ultrafine - PM0.1: Deposited on the alveolar surface, may 
enter the blood stream; associated with human illness. 
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area relative to their volume or mass (Oberdorster et al., 1994) as well as the greatest 
efficiency at penetrating deep into the lungs (Sioutas et al., 2005).  
Collecting air pollution particles without modifying them has been a problem for scientists. 
Furthermore, once the particles are collected it has been difficult to separate PM into the 
above mentioned size fractions. Because of this, most research is done using material 
fractioned only by the upper size limit. As such, PM10 used in research is composed of PM10 
+ PM2.5 + PM0.1, and PM2.5 is composed of PM2.5 + PM0.1. In the rest of this book chapter, the 
use of PMX represents particulate matter up to X micrometers in aerodynamic diameter.  
1.1.2 Particle formation 
In general, two main processes form PM. The first process is the condensation of gases in the 
lower atmosphere. The second process is direct introduction of PM through mechanical 
means such as wind blowing over exposed soil or human activities that stir up dust 
particulates such as farming and construction activities (Figure 1). Industry and combustion 
also directly introduce particulates into the atmosphere. Source variability and formation 
processes affect size distribution and particle composition of PM. Particles larger than 10 µm 
in diameter are primarily generated by wind blowing over soil whereas human activities, 
particularly the combustion of fossil fuels, are by far the greatest generators of PM10.  
1.2 Regulation of particulate matter 
In 2005, the World Health Organization updated the daily and annual mean guidelines of 
acceptable air pollution. These standards are still in effect and advise that within a 24-hour 
period, the mean level of PM2.5 should not exceed 25 µg/m3 and the mean level of PM10 
should not exceed 50 µg/m3. Furthermore, over the course of a year, the mean level of PM2.5 
should not exceed 10 µg/m3 and the mean level of PM10 should not exceed 20 µg/m3. Mean 
standards per 24-hours are higher than mean standards per year to allow for infrequent air 
pollution events caused by non-controllable factors such as wild fires or weather pattern 
changes. Data gathered prior to 2000 suggest that most large American cities would not 
have met these updated standards (Peng et al., 2005); however, PM10 levels are gradually 
decreasing with the implementation of pollution-minimization measures. 
 
Fig. 1. Particulate matter is introduced into the atmosphere through many human activities 
including vehicle emissions (panel a), industrial towns in developing countries like China 
(panel b) and general farming practices (panel c). Image credits E Tranfield.  
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1.3 Worldwide air pollution standards 
The guidelines set by the World Health Organization in 2005 are not followed by all 
countries (Table 1). Current efforts are being made by most developed countries to reduce 
the levels of air pollution and achieve these guidelines. Although a lot of progress has been 
made to reduce air pollution production in general, and PM production specifically, further 
reductions are required. Moreover, in rapidly developing countries like China, and India, 
which are currently some of the greatest sources of pollution, only minimal efforts are being 
made to reduce the generation of pollution.  
1.4 The global nature of air pollution 
Fine particulates are small enough to remain suspended in the air for long periods of time 
and to be transported by prevailing winds over long distances. This means that pollutant 
production can have a global impact and there is evidence that pollution from China has 
reached the west coast of North America. Efforts by individual countries will have local 
effects on air quality but to generate long-term global health benefits air pollution will need 
to be prevented, regulated and monitored on a global scale.  
Country Pollutant Targeted limits References 
Australia PM10 24 hr maximum: 50 µg/m3 Australian 
Government, 2009 PM2.5 24 hr maximum: 25 µg/m3; 
Annual maximum: 8 µg/m3 
Canada PM2.5 24 hr maximum: 30 µg/m3 Canadian Council of 
Ministers of the 
Environment, 2000 
European Union PM10 24 hr maximum: 50 µg/m3; 
Annual maximum: 40 µg/m3
European 
Commission 
Environment, 2011 PM2.5 Annual maximum: 25 µg/m3 
United States of 
America 




PM2.5 24 hr maximum: 35 µg/m3; 




PM10 24 hr maximum: 50 µg/m3; 
Annual maximum: 20 µg/m3 
World Health 
Organization, 2005 
PM2.5 24 hr maximum: 25 µg/m3; 
Annual maximum: 10 µg/m3 
Table 1. Examples of ambient particulate matter guidelines.  
2. Understanding particulate matter induced human morbidity and mortality 
Efforts to understand the sequence of events and the mechanisms through which air 
pollution affects human health have relied on two complimentary approaches.  
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The first approach is to use epidemiological investigations to study an illness in a large 
group of people and determine trends and patterns between the illness and potential causes 
of this illness. Epidemiological investigations are an effective public-health approach used to 
rapidly narrow down the potential causes of an illness but with little understanding of the 
underlying biochemical processes taking place. 
 
The second approach is to use medical research to understand the biochemical processes 
that are occurring within each person at the organ, tissue and even protein level. Medical 
research is more specific than epidemiological investigations in determining the cause of a 
medical event through a detailed understanding of the sequence of processes happening in 
the body. However, since medical research is very time consuming, epidemiological 
investigations help to rule out potential causes of illness, thus efficiently reducing the scope 
for medical investigations. 
Scientists have been using a combination of these two approaches to understand how 
exposure to air pollution, particularly PM, is impacting processes within the body and 
leading to cardiovascular and pulmonary morbidity and mortality.  
2.1 Epidemiological investigations 
2.1.1 Human awareness of the impact of air quality on health 
The first known environmental legislation was documented in Israel about 2000 years ago. 
Practitioners of the Jewish religion suspected a relationship between human illness and the 
foul odors of tanneries as well as the airborne waste products from threshing floors. Laws 
stipulated that industries should be located down-wind of cities and towns to minimize the 
exposure of citizens to airborne pollutants (Mamane, 1987).  
Over 1600 years later, in 1661, John Evelyn wrote to the King of England regarding the soot 
in the air over London. He attributed chronic coughs and pulmonary mortalities to the air 
quality and he put forward recommendations to move industry outside the city to reduce 
air pollution (Evelyn, 1965). The suggestions of John Evelyn were ignored and air pollution 
levels continued to rise, pushed upwards by the 18th century industrial revolution.  
In 1930, 63 people died during an air pollution episode in the Belgian Meuse Valley 
(Nemery et al., 2001). In 1948, 20 people died, several animals died and 43% of the 14,000 
inhabitants became ill after a weather inversion in the highly industrialized town of Donora, 
Pennsylvania, trapped coal smoke, sulphur dioxide, soluble sulphates, and fluorides over 
the city (Schrenk et al., 1949). Yet, the event cited as the major turning point in air pollution 
awareness and public policy did not occur until 1952. In December of that year, London, 
England, suffered an absence of wind and a temperature inversion resulting in a very dense 
fog over the Greater London area. PM produced by the burning of coal was trapped within 
the fog, leading to a rapid and extreme rise in air pollution followed closely by a rapid and 
Epidemiological investigations and medical research 
are two complementary approaches that are used to 
understand how air pollution affects human health. 
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extreme rise in mortality rates. During the infamous four day pollution event in excess of 
4000 deaths above typical levels occurred (Logan, 1953). In response to the startling number 
of air pollution related deaths, the British Parliament passed a Clean Air Act in 1956 to 
reduce emissions of airborne pollutants.  
Since 1952 the search for the causative agent of air pollution related mortality has been 
pursued and gradually narrowed down to PM10. In 1979 an epidemiological investigation 
suggested airborne particulates were responsible for some of the observed cardiopulmonary 
health effects (Holland et al., 1979). Nonetheless, it was not until a standardized definition of 
PM was introduced in 1987 by the United States Environmental Protection Agency, and 
statistical analysis was used to remove major confounding factors including smoking, 
socioeconomic status, and body-mass index that the first robust positive association between 
mortality and PM air pollution was established in 1993 (Dockery et al., 1993). 
2.1.2 Epidemiological evidence 
Today epidemiological studies present strong evidence that exposure to ambient PM10 
contributes to cardiopulmonary morbidity and mortality (Dockery et al., 1993; Pope, 1989; 
Samet et al., 2000). Cardiovascular diseases are much more common in the world than 
pulmonary diseases and so there are more cardiovascular events following PM10 exposure 
than there are pulmonary events. Specifically, the number of heart attacks, strokes, 
aggravations of heart failure, cardiac arrhythmias and sudden deaths increase within hours 
of exposure to elevated levels of PM10 (Hong et al., 2002; Peters et al., 2000; Peters et al., 2004; 
Pope et al., 2004; Schwartz, 1994).  
2.1.3 Limitations of epidemiological investigations 
Epidemiological investigations can establish strong patterns and associations between an 
event and a cause, in this case between cardiovascular morbidity and mortality and ambient 
PM10 exposure. Epidemiological investigations can suggest organs, and tissues of interest 
that should be studied in detail by medical research but epidemiological investigations 
cannot explain the detailed biochemical processes that are occurring in the body as a result 
of air pollution exposure – for that scientists rely on medical research.  
2.2 Medical research 
2.2.1 Pulmonary health concerns 
Air pollution predominately enters the body during breathing; therefore, investigating the 
effects of PM inhalation on the lungs was an initial focus of many research groups interested 
in air pollution. There is an extensive amount of literature in this field and the authors refer 
readers to the following reviews for more information on this topic (Ko et al., 2009; 
Laumbach, 2010; Ling et al., 2009; Liu et al., 2008).  
To briefly summarize the progress made in the field, it has been found that short-term 
exposure to high levels of PM10 and ozone lead to altered pulmonary function in children 
and in adults (Kelly et al., 2011; Sheppard et al., 1999). The consequences of long-term 
exposure to high levels of PM10 include worsening of chronic obstructive pulmonary disease 
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(COPD)(Liu et al., 2008), and the development of chronic bronchitis and potentially lung 
cancer, although the later is still under debate (Gamble, 2010). Additionally, research has 
shown compromised lung development in children (Gauderman et al., 2007) and an 
increased risk of developing asthma and allergies (Kelly et al., 2011). Populations at risk of 
serious pulmonary consequences when exposed to elevated levels of pollutants are the 
elderly (Schwartz, 1995) or individuals with existing conditions such as pneumonia (Knox, 
2008), asthma or COPD (Pope et al., 1995).  
As the epidemiological evidence became stronger that exposure to PM also had an effect on 
the cardiovascular system, research groups began to study the underlying processes that 
might be responsible for cardiovascular related morbidity and mortality.  
2.2.2 Cardiovascular health concerns 
Introduction to cardiovascular disease and terminology 
Before we look in detail at some of the medical research on this topic, it is important to 
understand the basic architecture of a healthy blood vessel. A blood vessel has three layers: 
the adventitia, the media and the endothelium. The media is the middle layer and the 
muscle layer of the blood vessel. It is populated with many smooth muscle cells. For arteries 
the media is quite thick, but for veins the media is rather thin. The innermost layer of the 
blood vessel is the endothelium, which is made of a single layer of endothelial cells that are 
anchored to a thin layer of structural proteins called the extracellular matrix (ECM). The 
endothelium is the barrier between the blood in the blood vessel and the cells and proteins 
of the blood vessel. Just like the liner of a swimming pool, if small holes appear in the 
endothelium it will cause problems. Blood clots, medically called a thrombosis, will form to 
prevent leakage of the blood vessel. A large thrombosis can block blood flow where it forms, 
or it can break off and travel in the blood until it gets stuck fully blocking a small blood 
vessel. A blocked blood vessel in the heart results in a heart attack (medically called a 
myocardial infarction), a blocked blood vessel in the brain results in a stroke. Events such as 
these are very rare when the blood vessel wall is healthy, but these events increase when the 
blood vessel is diseased such as when a person has atherosclerosis. Atherosclerosis is a 
disease of the medium and large blood vessels, typically characterized by fatty deposits 
under the endothelium of the vessel wall. A stable atherosclerotic plaque has lipid 
accumulation at the core, and a “cap” of smooth muscle cells and ECM (Virmani et al., 2002) 
(Figure 2a). This cap is important in keeping the lipid away from the blood and providing a 
stable anchoring surface for the endothelial cells. Myocardial infarctions and strokes 
typically occur when an area of an atherosclerotic plaque does not have a dense cap, and 
becomes unstable. The plaque may rip, crack or a region may break off. In all cases the 
contents of the plaque will come in contact with blood and a thrombosis will form blocking 
blood flow, either at the plaque or further downstream in the blood vessel. Individuals at 
risk of myocardial infarctions or strokes have large fatty atherosclerotic plaques that do not 
have a stable, dense cap (Virmani et al., 2002).  
White blood cells play an important role in atherosclerotic plaques. There are several 
different kinds of white blood cells, but the most important in atherosclerotic plaque 
development is the monocyte / macrophage. These cells are important cells in the immune 
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system. In their young form they circulate in the blood and are called monocytes. In 
response to a local immune signal indicated by signaling proteins called cytokines, 
monocytes can move out of the blood into the tissues and mature into immune cells called 
macrophages. Macrophages attempt to clear the foreign object, or infectious agent from the 
body. In the development of atherosclerotic plaques, monocytes easily enter the leaky blood 
vessel wall, become macrophages and take up the lipid that is accumulating in the wall. Fat 
filled macrophages are called macrophage-derived foam cells.  
Research has also shown that cytokines are produced in response to particles deposited in 
the lungs. Monocytes move into the lungs, where they become alveolar macrophages. 
Alveolar macrophages take up the particles in an effort to clear the particles from the body.  
The three mechanisms to explain how air pollution affects the heart 
The epidemiological link between PM10 exposure and cardiovascular related morbidity and 
mortality is convincing; however, the underlying biological mechanism(s) remain(s) unclear. 
There are three primary mechanisms by which PM air pollution may bring about 
cardiovascular events. These are the inflammatory mechanism, the dysfunction of the 
autonomic nervous system mechanism and the cardiac malfunction mechanism.  
 
The inflammatory mechanism was originally proposed by Seaton and colleagues (Seaton et 
al., 1995). They hypothesized that exposure to air pollution irritates the lungs, particularly in 
patients with existing pulmonary conditions such as asthma and chronic obstructive 
pulmonary disease. This results in the release of cytokines in the lungs. The cytokines enter 
into the blood and begin a low level immune response (also called an inflammatory 
response) through the body. Seaton and colleagues proposed that the resulting low-grade 
systemic inflammatory response was involved in the observed cardiovascular events 
following air pollution exposure. In 1999, Seaton and colleagues showed a correlation 
between a decrease in the number of circulating red blood cells and PM10 exposure (Seaton 
et al., 1999). Subsequent medical studies have shown that PM10 exposure results in platelet 
activation, (Nemmar et al., 2003) and early release of white blood cells, specifically 
neutrophils (Mukae et al., 2000) and monocytes (Goto et al., 2004), into the circulation. 
Furthermore, epidemiological studies on human populations have shown an increase in the 
number of circulating white blood cells (Tan et al., 2000), and increased clotting and 
inflammation indicators in the blood (Gilmour et al., 2005). These are all observations that 
support the theory put forward by Seaton and colleagues in 1995 that PM10 exposure leads 
to low-grade, body-wide inflammation.  
The second mechanism centers on the dysfunction of the autonomic nervous system 
resulting in changes in heart rate, heart rhythm and blood pressure. Epidemiological studies 
on human populations provide evidence that PM10 exposure results in a decrease in heart 
rate variability (Pope et al., 1999), and an increase in heart rate (Pope et al., 1999), cardiac 
The three mechanisms that attempt to explain how air 
pollution affects the heart are the inflammatory 
mechanism, the dysfunction of the autonomic nervous system 
mechanism and the cardiac malfunction mechanism.  
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arrhythmias (Peters et al., 2000), systolic blood pressure, (Ibald-Mulli et al., 2001) plasma 
viscosity (Peters et al., 1997), and arterial vasoconstriction (Brook et al., 2002). In animal 
studies, exposure to PM10 affects heart rate and blood pressure (Cheng et al., 2003), and 
increases arrhythmias (Watkinson et al., 2001), and fibrinogen levels (Ulrich et al., 2002). 
Together this data suggests that some component of PM triggers dysfunction of the 
autonomic nervous system, yet what that component is and how it triggers dysfunction 
remains unknown.  
The final proposed mechanism involves particulate induced cardiac malfunction caused by 
particulates in the blood stream (Nemmar et al., 2002; Oberdorster et al., 2000; Oberdorster 
et al., 2004) leading to local damage to the heart muscle (Park et al., 2005) as well as the liver 
(Oberdorster et al., 2000) and the blood vessels (Schulz et al., 2005). Of the three proposed 
mechanisms, the cardiac malfunction mechanism has the least research and supporting data. 
Understanding what processes are involved, how these processes are initiated and what the 
short- and long-term consequences of PM10 and PM2.5 exposure are is the focus of ongoing 
research. The big questions can be grossly simplified to this: how does the air we breathe 
cause changes in our cardiovascular system and in extreme cases lead to the rupture of 
atherosclerotic plaques?  
Medical research investigating how exposure to particulate matter affects the 
cardiovascular system 
Studies from the Davis Heart & Lung Research Institute at Ohio State University reported 
increased lipid deposits and macrophage invasion into the wall of atherosclerotic plaques in 
an atherosclerotic mouse model, (ApoE -/- mouse) following long-term exposure to low 
concentrations of PM2.5. In these same animals they reported reduced responsiveness of the 
blood vessel wall, and increased area of atherosclerotic plaques (Sun et al., 2005). They also 
found increased tissue factor expression, which is another indicator of inflammation, 
following exposure to particulate matter (Sun et al., 2008). Together these observations 
suggest a worsening of inflammation and atherosclerosis in mice after exposure to PM2.5.  
Work done by our laboratory at the James Hogg Research Center showed structural changes 
in atherosclerotic plaques from Watanabe Heritable Hyperlipidemic (WHHL) rabbits 
exposed to PM10 (Suwa et al., 2002; Tranfield et al., 2010; Yatera et al., 2008) and from ApoE  
-/- mice exposed to diesel exhaust (Bai et al., 2011). The observed changes were consistent 
with atherosclerotic plaques vulnerable to rupture.  
Light microscopic studies reported a trend towards larger atherosclerotic plaques, increased 
infiltration of inflammatory cells, recruitment of monocytes and increased amounts of lipid 
accumulation in the plaques from rabbits exposed to PM10. These studies document greater 
numbers of atherosclerotic plaques classified as advanced vulnerable plaques following 
exposure of the rabbits to PM10 (Suwa et al., 2002; Yatera et al., 2008). 
Our electron microscopy studies showed three critical findings: 1. an accumulation of 
macrophage-derived foam cells immediately below the endothelium of atherosclerotic 
plaque cores, 2. the separation of the endothelium from a previously undescribed reticulum 
of dense extracellular matrix (ECM) that serves as the supporting layer of atherosclerotic 
plaques, and 3. evidence of degradation or fragmentation of the dense ECM in regions of 
macrophage-derived foam cell accumulation (Tranfield et al., 2010). As a consequence of 
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fragmentation of the ECM, there was increased direct contact between macrophage-derived 
foam cells and the endothelial cells. Furthermore, increased macrophage-derived foam cell 
migration was observed over the core regions of atherosclerotic plaques from PM10 exposed 
rabbits. The evidence suggests that the cells were emigrating out of the atherosclerotic 
plaques and into the lumen of the aorta (Tranfield et al., 2010).  
In the atherosclerotic plaques of the rabbits exposed to PM10, we observed an absence of the 
dense ECM under the endothelial cells. Rather, we observed macrophage-derived foam cells 
(Figure 2b) or fragmented ECM (Figure 2c) under the endothelial cells, neither of which 
would provide a stable attachment surface for the endothelial cells. Quantification of these 
observations found that in PM10 exposed rabbits, 21.6% of the endothelial cell contacts were 
with fragmented ECM, whereas only 8.4% of endothelial contacts in control rabbits were in 
contact with fragmented ECM (p < 0.0001). The number of endothelial cell contacts with 
macrophage-derived foam cells was found to be 13.4% in the control rabbits and increased 
significantly to 38.1% in PM10 exposed rabbits (p = 0.0039) (Tranfield et al., 2010).  
 
Fig. 2. The wall of an atherosclerotic plaque from a control rabbit contained smooth muscle 
cells (SMC) and unique dense extracellular matrix (ECM) under the endothelial cells (EC) 
(panel a). The wall of an atherosclerotic plaque from a rabbit exposed to PM10 has large lipid 
filled macrophage-derived foam cells (MØFC) directly under the endothelial cells (EC) 
(panel b) or fragmented ECM near areas of MØFC accumulation (panel c). Scale bars: a.  
5 µm, b. 5 µm and c. 2 µm. Panel a and b originally published in Tranfield et al., 2010. 
To better understand changes in the contact between the dense ECM and the endothelial 
cells, serial thin section reconstructions were done using transmission electron microscopy 
(Figure 3). Many contacts between the endothelial cell and the ECM were observed in the 
reconstructions from the control rabbits. In contrast, the endothelial cell in the 
reconstructions from the PM10 exposed rabbits had a fragmented underlying ECM and few 
contacts between the ECM and the endothelial cell. These observations suggest decreased 
stability of the endothelial cell attachments following PM10 exposure. 
A distinction needs to be made between the core regions of an atherosclerotic plaque and 
the edges of an atherosclerotic plaque. In Figure 4a the edges of the plaque are outlined with 
white arrows whereas a white diamond marks the plaque core. Typically more stable 
atherosclerotic plaques grow from the edges with the center having a fibrous cap. Evidence 
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of cell migration, lipid accumulation and plaque expansion is expected at the growing 
edges. As we were interested in structural indicators of instability, we focused our research 
on the typically-stable plaque cores well away from the active edge regions. Using a 
combination of transmission electron microscopy and scanning electron microscopy we 
observed large lipid-filled cells exiting the core regions of the atherosclerotic plaques from 
PM10 exposed rabbits (Figure 4c, d, e and f). This finding was quite unexpected.  
 
Fig. 3. Three-dimensional reconstruction of the extracellular matrix (ECM, green in c and f) 
under an endothelial cell (EC, orange in c and f). Panels a-c are from a control rabbit. Panels 
d-f are from a PM10 exposed rabbit. Panels a and d are a single transmission electron 
micrograph from the series of reconstructed images. Panels b and e are the tracing of the 
endothelial cell and the dense extracellular matrix shown in panel a and d respectively. 
Panels c and f are the full reconstruction made of 20 serial tracings from thin sections and 
show that the contact area between the EC and the ECM is much greater in the control 
reconstruction than the PM10 reconstruction. Methodology and further figures are published 
in Tranfield et al., 2010.  
When all these observations are taken together we believe we have significantly contributed 
to the understanding of how air pollution may trigger cardiovascular events. An 
accumulation of macrophage-derived foam cells subtending the endothelium, decreased 
endothelial contact with a dense, stable reticulum of ECM material and the emigration of 
large leukocytes from atherosclerotic plaques are indicators of atherosclerotic plaque 
remodeling following PM10 exposure. Taken together with previous work, these findings 
illustrate mechanisms of remodeling following exposure to PM10 that may convert stable 
atherosclerotic plaques into unstable atherosclerotic plaques. Cardiovascular disease affects 
millions of people and it appears that PM10 exposure may be a considerable contributor to 
endothelial destabilization and dysfunction potentially being involved in millions of deaths 
annually. Although PM10 exposure is not usually considered an initiating risk factor for 
atherosclerosis, it appears to be an exacerbating risk factor, pushing existing atherosclerotic 
plaques to a more vulnerable phenotype. 
2.2.3 At-risk groups for cardiovascular complications following PM10 exposure 
Epidemiological investigations have identified several at-risk groups. Particulate air 
pollution exposure has been repeatedly linked to adverse events in individuals with a prior 
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Fig. 4. Electron micrographs of the aorta. Panel a: The core region () of an atherosclerotic 
plaque (outlined by white arrows) at a branch in the aorta (*). Panel b: Cell borders of healthy 
endothelium (black arrows). Panels c and d: Cell pushing between two endothelial cells into the 
blood vessel lumen. The border (black arrows) between the two endothelial cells (EC1 and EC2) 
and the EC finger-like projections up the side of the migrating cell (white arrows). Panel e and f: 
Transmission electron micrographs of a macrophage-derived foam cell pushing the endothelial 
cells aside (EC) as it emerges into the blood vessel lumen. Panel f: Extracellular matrix (arrow) 
caught above the migrating cell, which would only be possible if the cell is migrating out of the 
wall. Scale bars: e = 5 µm; f = 2 µm. All micrographs originally published in Tranfield et al., 2010. 
www.intechopen.com
 Environmental Health – Emerging Issues and Practice 94
myocardial infarction or chronic diabetes, both of which are associated with advanced 
atherosclerotic disease. Furthermore, exposure to PM2.5 had a significant effect in ApoE -/- 
mice fed high fat chow, whereas a diminished effect was observed in ApoE -/- mice on 
regular chow diets. Collectively, these observations suggest that PM exposure has a negative 
impact in combination with high lipid diets, and existing atherosclerosis. Atherosclerotic 
plaque disruption with thrombus formation is the predominant mechanism leading to 
unstable angina, myocardial infarctions and sudden death. Therefore, it seems likely that air 
pollution related morbidity and mortality may also be associated with advanced 
atherosclerotic disease and plaque disruption. 
2.2.4 PM10 exposure affects cardiovascular morbidity and mortality: A proposed 
mechanism 
If you will, imagine an individual who is aging, who has at least one or two major risk 
factors for atherosclerosis and who has been chronically exposed to low levels of air 
pollution. Epidemiological investigations repeatedly link PM10 exposure to adverse 
cardiovascular events in individuals with advanced atherosclerotic disease. Medical 
research from our laboratory and other laboratories demonstrates that the atherosclerotic 
plaques in an individual undergo destabilizing structural changes as a consequence of 
exposure to PM10. Combined, the data suggest that an individual will experience the 
progressive worsening and destabilization of their atherosclerotic plaques as a consequence 
of PM10 exposure. Now imagine an event that results in an increase in PM10 levels, such as a 
forest fire or a smog day in a large city. Epidemiology investigations and medical research 
suggest that at this point there will be a decrease in heart rate variability and an increase in 
circulating white cells and cytokines, and an increase in heart rate, cardiac arrhythmias, 
systolic blood pressure, arterial vasoconstriction, plasma viscosity, platelet activation, and 
fibrinogen levels. Combined, all of these factors result in an enhanced clotting 
(procoagulant) and enhanced inflammatory state of the circulating blood. What we have 
now in our hypothetical individual is vulnerable atherosclerotic plaques, increased 
reactivity of the blood and altered shear stress on the vasculature, a perfect deadly scenario 
for an acute cardiovascular event to play out as follows: as the blood pressure increases, the 
flow properties of the blood may change, and a vulnerable atherosclerotic plaque, whose 
endothelium has lost its extracellular matrix and had its surface shape and contours altered 
by emigrating foam cells, may rupture or break. The increased blood viscosity, fibrinogen 
levels and platelet activation aid in a large thrombus formation. If the thrombus does not 
fully fill the blood vessel and block blood flow, it may break off in the setting of increased 
luminal narrowing and vascular tone and be sent downstream in the progressively 
narrowing blood vessels. At some point this thrombus will get stuck, blocking blood flow 
leading to a heart attack or stroke, and potentially the death of the individual. Our 
hypothetical person has now become one of the 2 million people to die annually from air 
pollution exposure. The mechanisms involved in the death of our hypothetical person were 
not only the inflammatory mechanisms, but also the autonomic dysfunction mechanism. We 
propose that these two mechanisms are not separate; rather they are convergent processes 
that together lead to plaque destabilization and rupture as a consequence of chronic air 
pollution exposure. 
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3. Future actions to reduce the health consequences of air pollution 
The World Health Organization predicts that there are more than 2,000,000 premature 
deaths every year as a consequence of air pollution exposure. This number is far too high, 
particularly for the friends and family who have lost a loved one. Steps can be taken on 
several levels to reduce this number. To begin with, through continued epidemiological and 
medical research scientists can continue to uncover the underlying mechanisms for the high 
number of deaths. Secondly, measures can be taken at local, national and international levels 
to reduce the global production of air pollution.  
3.1 Research 
Since 1952 when so many people died during the London Fog, a great deal of insight about 
the effects of air pollution has been uncovered. However, scientists still do not fully 
understand the biochemical mechanisms underlying PM related deaths. Research in this 
field is needed to expand scientific understanding. These efforts would be made with the 
hope that greater scientific knowledge can lead to medical prevention of further fatalities. 
There are several overarching topics that should be investigated in further detail. The first is 
understanding the medical effects of individual pollutants, understanding who is at risk, 
what medical conditions these individual pollutants cause, or aggravate and why. Once this 
is better understood then efforts need to be made to understand how mixtures of pollutants 
act, and how mixtures of pollutants condense and modify over time. It will be important to 
understand if certain pollutants work synergistically to aggravate cardiopulmonary 
morbidity and mortality. It will be important to understand the acute and the chronic effects 
of the pollutants to predict subsets of the populations who are at greatest risk. Beyond this it 
will be important to understand the extent of the health effects of PM exposure on the 
otherwise healthy individuals in society.  
3.2 Reduce PM creation / Increase PM reduction measures 
In addition to research, measures can be taken to reduce the effects of PM by decreasing PM 
production and increasing PM removal from the atmosphere. To successfully accomplish a 
reduction in PM pollution steps can be taken at all levels of government. There is a great 
deal of literature already existing on this topic, but here are a few ideas to consider.  
3.2.1 Local 
At the local level individuals can make choices that reduce PM creation, such as purchasing 
locally grown food that is not transported great distances, or growing their own vegetables 
and fruit. Local governments can implement green programs that increase the use of bikes 
or carpools to reduce the use of cars for short trips. Efforts can be made to help homeowners 
make better choices in the selection of building materials for new homes, and help 
individuals make existing homes more energy efficient. Both individuals and communities 
can take measures to reduce energy waste, thereby reducing PM production. Taking action 
like bicycle commuting has multiple positive effects such as reducing a person’s risk of 
cardiovascular disease and obesity, reducing the production of PM and saving money on 
fuel. However, individuals will not commute without bike lanes and safety infrastructure 
thus this behavioral change needs support from local government.  
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3.2.2 National  
The contribution at the national level comes under two broad categories: financial and legal. 
The changes that will be required at the individual and local level will require a financial 
investment. Furthermore, nations should invest in research to understand the health 
consequences of pollution exposure as well as dedicate money to the development of less 
polluting technologies. Governments should consider the money they will save on health 
care expenses as justification for this expense.  
The legal category applies to government regulation of industry. Governments need to hold 
polluting industries responsible for the damage being done to the environment and human 
health. Though industry will not be in favor of tough regulations in line with the current 
recommendations of the World Health Organization, the regulations need to be 
implemented. This may require governments to financially assist companies as they 
transition to less polluting business practices. The transition will be expensive and 
challenging, but given the impact PM pollution production is having on human health and 
the environment, it is a transition that must be done.  
3.2.3 International/ global 
The contribution at the international and global levels is similar to the contribution at the 
national level: financial and legal. Countries need to hold each other accountable for the 
pollution that is being produced. China, one of the biggest suppliers of goods in North 
America, is also one of the countries producing a lot of pollution. In the international arena, 
countries need to decide if this is an acceptable situation.  
4. Conclusions 
Data from epidemiological investigations and medical research strongly suggest that 
exposure to fine particulate matter air pollution results in deposition of particulates in the 
lungs, activation of a systemic inflammatory response and alteration of the ultrastructure of 
atherosclerotic plaques. Air pollution levels can be controlled if individuals make efforts to 
reduce their pollution production, and governments at the local, national and international 
levels invest in green infrastructure, and green technology to reduce pollution production as 
well as invest in ongoing medical research to understand the biological mechanisms 
underlying air pollution related morbidity and mortality. It will take a coordinated effort to 
globally reduce the production of air pollution and reduce the effect air pollution has on 
human health.  
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